Categories: News

American Kidney Fund Commends Kentucky Governor Andy Beshear and General Assembly for Passing Living Organ Donor Protections into Law

HB 75 provides living organ donors with insurance protections, improving Kentucky’s grade on AKF’s Living Donor Protection Report Card

ROCKVILLE, MD / ACCESSWIRE / March 23, 2021 / The American Kidney Fund (AKF) commends Kentucky Governor Andy Beshear for signing HB 75, the Living Donor Protection Act of 2021, into law. The bill will prohibit life, disability and long-term care insurers from discriminating against living organ donors by charging higher premiums or denying them coverage.

“Governor Beshear and the Kentucky General Assembly have taken a critical step toward removing barriers to living organ donation,” said LaVarne A. Burton, AKF president and CEO. “HB 75 will ensure that Kentucky residents won’t face discrimination by insurers for giving someone a lifesaving organ. We applaud Kentucky for passing this law and hope that it will lead to more people deciding to be living organ donors in the state-ultimately shortening the transplant waiting list.”

AKF worked closely with sponsors Representative Jerry Miller (R-36) and Representative Shawn McPherson (R-22) to move this bill through the Kentucky General Assembly. AKF is leading a nationwide effort to pass living donor protections at the state level. Kentucky is the first state to enact such legislation this year, joining the 12 other states that have put these protections into place since 2019, thanks to legislation spearheaded by AKF.

HB 75 is the second living donor protection legislation signed into law in Kentucky. It will move the state up from a D grade to a C on AKF’s annual State of the States: Living Donor Protection Report Card. AKF’s Report Card, which was released in February, identifies seven different categories of publicly reported legislation in each U.S. state and the District of Columbia that protect living donors and encourage living organ donation. In the absence of federal legislation to protect living donors, there is an uneven patchwork of protections across the nation, with some states providing no protections at all.

Most transplanted organs are from deceased donors, but patients may also receive organs from living donors. Living donation offers an alternative for individuals awaiting transplantation from a deceased donor and increases the existing organ supply. Transplants from living donors generally have fewer complications than deceased-donor transplants and a longer survival of the donor organ.

There are 108,000 Americans on the organ transplant waiting list and 93,000 of them, or 86%, are waiting for a kidney. In Kentucky, more than 750 people are on the kidney transplant waiting list. Of the 23,644 kidney transplants performed in the U.S. in 2020, just 5,234 were made possible by living organ donors. In Kentucky, just 39 of 216 kidney transplants were from living donors.

Among its many programs, AKF provides long-term financial assistance that makes transplants and post-transplant care possible for low-income kidney failure patients. In 2020, AKF’s assistance made 1,615 transplants possible-7% of all kidney transplants performed in the U.S. AKF’s program helps post-transplant patients for their full insurance plan year, ensuring continuity of care.

About Us
As the nation’s leading independent nonprofit working on behalf of the 30 million Americans with kidney disease, the American Kidney Fund is dedicated to ensuring that every kidney patient has access to health care, and that every person at risk for kidney disease is empowered to prevent it. AKF provides a complete spectrum of programs and services: prevention outreach, top-rated health educational resources, and direct financial assistance enabling the nation’s low-income dialysis and transplant patients to access lifesaving medical care. AKF holds the highest ratings from the nation’s charity watchdog groups, including Charity Navigator, which includes AKF on its “top 10” list of nonprofits with the longest track records of outstanding stewardship of the donated dollar, and GuideStar, which has awarded AKF its Platinum Seal of Transparency.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.

CONTACTS
Ben Shannon
AKF@jpa.com
11921 Rockville Pike, Suite 300, Rockville, MD 20852
Work: 202-559-2813
Mobile: 919-360-3039
www.kidneyfund.org/

SOURCE: American Kidney Fund

View source version on accesswire.com:
https://www.accesswire.com/637125/American-Kidney-Fund-Commends-Kentucky-Governor-Andy-Beshear-and-General-Assembly-for-Passing-Living-Organ-Donor-Protections-into-Law

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

4 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

5 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

5 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

8 hours ago